07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago.

Analysts polled by Capital IQ expected $1.92.

Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier.

Analysts surveyed by Capital IQ expected $15.20 billion.

For 2024, Merck ( MRK ) said it now expects non-GAAP EPS of $8.53 to $8.65, up from its prior outlook of between $8.44 and $8.59. Analysts polled by Capital IQ expect $8.56.

Sales for the year are now expected to be $63.1 billion to $64.3 billion, also higher than its previous guidance of between $62.7 billion and $64.2 billion. Analysts surveyed by Capital IQ expect $63.82 billion.

Price: 128.57, Change: +1.57, Percent Change: +1.24